SkinVive by Juvederm is an FDA-approved hyaluronic acid skin booster injected as microdroplets to improve cheek and neck skin smoothness, hydration, and glow, not to add volume. See how it works, results, cost, safety, and how it compares.
SkinVive by Juvederm is an FDA-approved hyaluronic acid skin booster injected as tiny microdroplets into the cheeks to improve smoothness, hydration, and radiance in adults over 21. Unlike traditional fillers, it enhances skin quality rather than adding volume, with results lasting about six months.
*FDA status: SkinVive by Juvederm (modified hyaluronic acid with lidocaine) is FDA-approved to improve cheek skin smoothness (2023) and neck appearance (2026) in adults over 21. Use in any other area is off-label. Educational content, not medical advice.*
SkinVive by Juvederm has become one of the most talked-about injectables in aesthetics because it promises something different from a classic filler: not more volume, but better skin. If you have seen the glass-skin or injectable-moisturizer buzz and wondered what SkinVive actually is, how it works, what it costs, and whether it lives up to the claims, this guide walks through the evidence, the honest limits, and how it stacks up against the alternatives.
**SkinVive by Juvederm is a hyaluronic acid (HA) injectable made by Allergan Aesthetics, an AbbVie company.** It belongs to a category clinicians call a skin booster or injectable moisturizer. It is technically classified as a dermal filler, yet it works differently from the fillers most people picture. Traditional HA fillers such as Juvederm Voluma or Ultra are placed in larger amounts to add structural volume, sharpen a contour, or plump a lip. SkinVive is deposited as tiny microdroplets in the mid-dermis across the surface of the cheek, where its purpose is to raise the water content of the skin rather than build shape.
The gel is a smooth, modified HA made with Allergan's VYCROSS crosslinking technology and includes a small amount of lidocaine to ease discomfort. Because hyaluronic acid is a humectant that binds many times its weight in water, the microdroplets act like reservoirs of hydration spread evenly through the treated area. Over the weeks that follow, that retained moisture is what softens fine surface texture and lends the skin a dewier, more reflective quality. The effect is a refreshed, well-hydrated look rather than a filled or augmented one.
| SkinVive at a glance | |
|---|---|
| Type | Hyaluronic acid skin booster (microdroplet injectable) |
| Active ingredient | Modified HA (VYCROSS) with lidocaine |
| FDA-approved for | Cheek smoothness (2023), neck appearance (2026), adults 21+ |
| Primary benefit | Smoothness, hydration, radiance (not volume) |
| Results appear | 2 to 4 weeks |
| Results last | About 6 months |
| Downtime | Minimal; temporary bumps common |
| Reversible | Yes, dissolvable with hyaluronidase |
SkinVive received U.S. FDA approval in May 2023 to improve skin smoothness of the cheeks in adults over the age of 21, making it the first and only HA microdroplet injectable cleared for that purpose in the United States. In June 2026 the FDA granted a second indication: improvement of neck appearance, specifically horizontal (transverse) neck lines, again in adults over 21. For the neck indication the FDA required providers to complete a training program before they can purchase or administer the product.
In the pivotal cheek trial, 58% of patients showed at least a one-point improvement on a validated smoothness scale at one month and 56% at six months. In the neck study, roughly 75% saw a clinically significant improvement at one month. So the honest answer to whether it really works is yes for skin quality, within limits: it improves smoothness, hydration, and radiance, but it does not lift sagging skin, erase deep folds, or replace lost volume.
Good candidates are adults bothered by dull, dehydrated, or crepey-looking cheek or neck skin who want a subtle refresh. It is not the right tool for deep nasolabial folds, hollow cheeks, or significant laxity, which call for structural filler, biostimulators, or energy-based devices. Any use outside the cheeks and neck, such as the lower face, hands, or under-eyes, is off-label and not supported by the FDA-cleared indications.
A SkinVive session is quick and done in an office setting. After cleansing, many injectors apply a topical numbing cream, though the lidocaine already in the gel provides additional comfort. The provider then delivers a series of small microdroplet injections across the cheek, or, for the neck indication, along the horizontal neck lines, using a fine needle to place the gel in the mid-dermis. A typical cheek treatment uses a modest amount of product per side and takes roughly 15 to 30 minutes.
Because the deposits are tiny and shallow, you may see small raised bumps or a slightly bumpy, orange-peel texture immediately afterward. This is expected and usually settles within hours to a few days as the gel integrates and the water disperses. Most people can return to normal activities right away, though injectors commonly advise avoiding strenuous exercise, heat, alcohol, and makeup for the first 24 hours to limit swelling and bruising. There is little to no true downtime, which is part of the appeal for people who want a low-commitment refresh.
SkinVive is not an instant-gratification treatment in the way a lip filler is. You will not walk out visibly plumped. Instead the hydration and glow build gradually as the HA draws and holds water in the skin. Most people begin to notice smoother, more radiant skin within two to four weeks, with the full effect visible around the one-month mark.
In the pivotal cheek study, patients reported meaningfully higher satisfaction with skin radiance (63% at six months versus 11% before treatment) and hydration (72% versus 24% at baseline). Results typically last about six months, after which the HA is gradually broken down by the body and the effect fades. To maintain the look, treatments are usually repeated roughly twice a year, and some providers suggest an initial pair of sessions spaced about a month apart for people with drier or more textured skin. Because it is temporary and non-permanent, SkinVive is easy to try without a long-term commitment, but ongoing results require ongoing maintenance and repeat cost.
Several variables shape how much benefit you see and how long it lasts. Baseline skin quality matters: someone with mild dehydration and early texture change tends to see a more dramatic before-and-after than someone whose main concern is deep lines or sagging, which SkinVive does not address. The amount of product used is another factor. Many people ask how many syringes they need; a common approach is one syringe divided between both cheeks per session, but larger treatment areas, the neck, or drier skin may warrant more, and your injector should tailor the dose to your anatomy rather than a fixed formula.
Injector skill and placement depth strongly influence both the evenness of the glow and the risk of lumps. Lifestyle also plays a role: sun exposure, smoking, dehydration, and an inconsistent skincare routine can blunt or shorten the effect, while good sun protection and a solid moisturizing regimen help preserve it. Metabolism varies too, so the same treatment can last a bit longer or shorter from one person to the next.
SkinVive has a well-characterized safety profile typical of hyaluronic acid injectables, but no injectable is risk-free. The most commonly reported side effects in trials were injection-site reactions: redness, lumps or bumps, swelling, bruising, pain, tenderness, firmness, discoloration, and itching. Most of these are mild and resolve within about seven days. Small papules or bumps at the injection points are especially common in the first day or two and are generally a normal part of how the microdroplets settle, not a complication.
Less common but more serious risks apply to all HA fillers, including delayed-onset nodules, infection, and, rarely, accidental injection into a blood vessel, which can cause vascular compromise and, in very rare cases, tissue damage or vision problems. This is why technique and provider training matter, and why the neck indication carries a mandatory training requirement. SkinVive should be avoided by people with a history of severe allergic reactions or anaphylaxis, allergy to HA or lidocaine, or active skin infection at the treatment site, and it has not been studied in pregnancy or breastfeeding. Because HA fillers can be dissolved with the enzyme hyaluronidase, most SkinVive-related lumps or misplacements can be corrected if needed, an advantage over permanent products.
SkinVive is priced as an out-of-pocket cosmetic treatment and is not covered by insurance. Cost varies widely by geographic market, provider experience, and the amount of product used, so any figure should be treated as a general range rather than a quote. A single SkinVive session commonly falls somewhere in the range of a few hundred to under a thousand dollars, often quoted per syringe or per treatment, and treating both cheeks in one visit is typical.
Because results last about six months, budgeting realistically means planning for roughly two sessions a year to maintain the effect, so the annual cost is what matters most. Whether it is worth it is subjective and depends on your goals: people seeking a subtle hydration-and-glow refresh tend to be satisfied, while those hoping for lift, volume, or wrinkle erasure are often better served by a different treatment. Always ask for a personalized quote at consultation, and be cautious of prices that seem far below market, which can signal diluted product or an inexperienced injector.
It helps to place SkinVive against the treatments people most often compare it to. Versus traditional Juvederm fillers such as Voluma, Volux, or Ultra: those are volumizers designed to add structure, restore cheek fullness, define the jaw, or plump lips, and their results last one to two years. SkinVive is from the same Juvederm family and is technically a filler, but it is used to improve skin quality, not to add volume, and it lasts about six months.
Versus Sculptra: Sculptra is a poly-L-lactic acid biostimulator that prompts your own collagen to rebuild over months for gradual, longer-lasting volume and firmness, so it addresses structure and deeper volume loss rather than surface hydration. The two are not interchangeable, and some people combine a biostimulator for support with SkinVive for glow. Versus microneedling, chemical peels, or medical-grade skincare: those improve texture and tone from the outside or by remodeling the skin, whereas SkinVive works from within by holding water in the dermis, and the approaches are often complementary.
| Treatment | What it does | Typical duration |
|---|---|---|
| SkinVive | Improves skin smoothness, hydration, glow | About 6 months |
| Juvederm Voluma/Ultra | Adds volume, contour, lip/cheek shape | 1 to 2 years |
| Sculptra | Stimulates collagen for gradual volume/firmness | 2+ years |
| Microneedling/peels | Resurfaces texture and tone | Varies; series-based |
The simplest way to think about it: choose SkinVive when your goal is smoother, dewier, better-hydrated skin, and choose a filler, biostimulator, or energy device when your goal is volume, lift, or contour.
Because SkinVive results and safety depend heavily on injection technique and depth, the provider you choose matters more than the brand on the box. Look for a licensed and experienced injector, such as a board-certified dermatologist or plastic surgeon, or a trained nurse injector or physician associate working under appropriate medical supervision. For the neck indication in particular, confirm that the provider has completed the FDA-required SkinVive neck training.
Ask how many SkinVive treatments they have performed, request before-and-after photos of real patients, and make sure they take a full medical history and set realistic expectations, including that this is a hydration-and-smoothness treatment, not a volumizer or a lift. A good consultation should also cover aftercare, the likelihood of temporary bumps, and how touch-ups or dissolving would be handled if you were unhappy. When you are ready, injector.world can help you find a qualified, verified provider near you.
It is technically a hyaluronic acid filler in the Juvederm family, but it is used differently. Voluma and other fillers add volume and contour. SkinVive is placed as microdroplets to improve skin smoothness, hydration, and glow, not to add shape, and it lasts about six months rather than one to two years.
They do different jobs, so neither is simply better. Sculptra is a collagen biostimulator that rebuilds deeper volume and firmness over months and lasts two or more years. SkinVive is a surface hydration and smoothness booster lasting about six months. Choose Sculptra for volume and structure, SkinVive for glow; some plans use both.
A common starting point is one syringe divided between both cheeks per session, but the right amount depends on your skin, the treatment area, and whether the neck is included. Drier or larger areas may need more. Your injector should tailor the dose to your anatomy rather than apply a fixed number.
It depends on your goal. People wanting a subtle, natural boost in hydration, smoothness, and radiance tend to be satisfied, and trial data support improved glow and hydration. It is not worth it if you expect volume, lift, or wrinkle erasure, which need a different treatment. Results are temporary and require repeat maintenance.
Skinvive before-and-afters show smoother, more hydrated, more reflective cheek skin (not added volume or lift) with the change appearing over about 4 weeks and lasting roughly 6 months. It softens fine crepiness and dullness; it does not correct deep folds, hollowing, or sagging. Photos are heavily lighting-dependent.
Skinvive by Juvederm is microdroplet hyaluronic acid placed just under the skin surface, FDA-approved in 2023 to improve cheek skin smoothness in adults over 21. Because the effect is a glass-like quality of the skin rather than a change in shape, before-and-after photos are genuinely hard to capture: be skeptical of dramatic galleries. Expect small bumps at the injection points for a day or two, sometimes bruising, and swelling that resolves within a few days. Patients most likely to be happy are those with dull, dehydrated, fine-textured skin. Patients with volume loss, deep nasolabial folds, or laxity will be disappointed and are better served by filler, a biostimulator, or an energy device.
Skinvive by Juvederm is a hyaluronic acid microdroplet injectable, FDA-approved in 2023, that improves cheek skin smoothness and hydration: it is not a filler and adds no volume. It was the first injectable of its kind approved in the US, and results last about 6 months.
Skinvive is injected as many tiny droplets into the superficial layer of the skin rather than as a bolus of volume, so it changes skin quality (hydration, smoothness, light reflection), not facial shape. It is approved for improving cheek skin smoothness in adults over 21. Results build over about 4 weeks, after which retreatment is needed to maintain them. Expect injection-point bumps for a day or two, possible bruising, swelling, and tenderness. It is often called a "skin booster," and it is the only product in that category with US approval: Profhilo, its best-known European counterpart, is not FDA-approved. A June 2026 approval added neck lines; use elsewhere, including the lips, is off-label.
Skinvive typically costs $500-$900 per treatment in the US as of 2026, with most patients treating both cheeks in a single session and repeating it about every 6 months, or roughly $1,000-$1,800 a year. Prices vary by market, and some clinics recommend an initial series of two sessions.
Skinvive is usually priced per syringe or as a flat per-treatment fee, and one treatment commonly covers both cheeks. Because it is a skin-quality treatment rather than a volumizer, it is often bundled with toxin or filler, and package pricing can bring the effective cost down. Judge value against what it actually does: better hydration, smoothness, and light reflection in the cheeks, not lift, not volume, not correction of deep folds. If your concern is sagging or hollowing, spending the same money on filler or a biostimulator will serve you far better. Alternatives like microneedling or laser resurfacing address texture at comparable cost through a different mechanism.
Profhilo is a stabilized hyaluronic acid skin booster that improves skin hydration, firmness, and quality, but it is not FDA-approved and is not available in the US. It is widely used in the UK and EU, where a course is two sessions four weeks apart. The closest US-approved alternative is Skinvive by Juvederm.
Profhilo is injected at five fixed points per side of the face, with results lasting roughly six months. European before-and-afters show subtle improvement in skin smoothness, hydration, and mild firmness, not volume or lift, and not correction of deep folds. Because it is not FDA-approved, any Profhilo offered in the US is imported outside regulatory channels, with the attendant risks of unverified sourcing and sterility. If you are in the US and want a skin-quality injectable, Skinvive is the approved option, cleared in 2023 for improving cheek skin smoothness and lasting about six months. Microneedling and laser resurfacing address similar concerns through different mechanisms. Long-term evidence for durable skin remodeling from any skin booster remains limited.
Skinvive satisfies patients who wanted better skin hydration and smoothness in the cheeks and understood that it adds no volume; it disappoints those expecting lift, plumping, or correction of lines. Results are subtle, take about 4 weeks, and last around 6 months at $500-$900 per treatment.
The consistent theme in positive feedback is a "glass skin" quality (skin that looks more hydrated and reflects light better), and smoother makeup application. The consistent theme in negative feedback is that the change was too subtle to justify the price, particularly for patients whose real concern was volume loss or laxity, which Skinvive does nothing for. It is the only product in the skin-booster category with FDA approval in the US, which is a genuine point in its favor over grey-market alternatives. Long-term data beyond the approval studies is still limited, so claims about cumulative skin remodeling should be treated cautiously. Expect small injection bumps for a day or two and possible bruising. Choose it for skin quality, not shape.